Clinical Trial Update: Strategy of Surgical Resection With Adjuvant Therapy for IIIA NSCLC and N2 Disease Only in Subaortic or Paraaortic Level

View source ↗

Summary

A clinical trial evaluating surgical resection with adjuvant therapy for stage IIIA non-small cell lung cancer with N2 disease limited to subaortic or paraaorti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Pusan National University Hospital | Conditions: Lung Cancer, Cancer of Lymph Node | Status: UNKNOWN